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DObjective:Our objective was to evaluate the early and midterm outcomes of palliative arterial switch operation in
which a ventricular septal defect was not closed or repaired with a fenestrated patch in patients with transposition
of the great arteries, ventricular septal defect, and severe pulmonary vascular obstructive disease.
Methods: Between March 2000 and September 2009, the palliative arterial switch operation was performed in 21
patients with a mean age of 3.7 years (range, 0.5–15). Mean preoperative values for systolic pulmonary arterial
pressure and systemic arterial oxygen saturation were 91 mm Hg and 69%, respectively. Eighty-one percent of
the patients were in New York Heart Association functional class III or IV preoperatively.
Results: Early mortality was 14.3%. Mean follow-up was 4.0 years (maximum 9.5 years). Regression of pulmo-
nary arterial pressure occurred in 8 patients (44% of the early survivors). Three of the 8 fenestrations were closed
interventionally. Mean postoperative systemic arterial oxygen saturation increased significantly to 93%
(P< .001). One late death occurred 3 months after surgery. All the long-term survivors (n ¼17) were in New
York Heart Association functional class I or II (P< .001).
Conclusions: The palliative arterial switch operation significantly improved the quality of life and possibly life
expectancy in patients with transposition of the great arteries, ventricular septal defect, and severe pulmonary
vascular obstructive disease. Postoperative pulmonary vascular resistance might be reversible in some patients.
Closing the ventricular septal defect with a fenestrated patch, which can be easily closed nonsurgically later on,
might contribute to a safer postoperative recovery. (J Thorac Cardiovasc Surg 2010;140:845-9)The arterial switch operation (ASO) for transposition of the
great arteries (TGA) and ventricular septal defect (VSD)
is currently the best treatment option.1-3 With timely
diagnosis, most children with TGA/VSD usually undergo
surgical correction within the first 1 to 3 months after birth.
In developing countries, however, for socioeconomic
reasons, some of these children unfortunately are brought
for surgical correction when they are beyond 6 months of
age with severe pulmonary hypertension (PH) owing to
pulmonary vascular obstructive disease (PVOD).4 In general,
patients with isolated VSD and PH with pulmonary vascular
resistance (PVR) in excess of 8 U/m2 are considered inoper-
able. In 1972 Lindesmith and associates5 first reported a series
of patients who presented late with TGA/VSD and PVODe Department of Pediatric Cardiovascular Surgery,a Guangdong Provincial
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The Journal of Thoracic and Caand subsequently underwent palliative atrial switch opera-
tions with the VSDs left open. This approach, however,
was associated with long-term symptomatic arrhythmia and
baffle obstruction.6,7 During the past decade, several case
reports of palliative ASO for late presentation of TGA/
VSD with PVOD were contributed by Pridjian,8 Elizari,9
and their colleagues. This present report is, to our knowledge,
the first article to analyze a series of patients with TGA/VSD
and severe PVOD who were treated by palliative ASO.PATIENTS AND METHODS
Between March 2000 and September 2009, 21 children with TGA, mod-
erate to large VSD, and PVOD underwent palliative ASO in our institution.
Approval was obtained by the institutional review board. The medical
records of these patients, specifically patient demographics, preoperative
and postoperative hemodynamics and functional status, operative proce-
dures, 30-day hospital mortality and major morbidity, and all the investiga-
tive data during the follow-up period were reviewed and analyzed.
Seventeen children were male. Mean age at the time of palliative ASO
was 3.7  3.4 years (range, 0.5–15 years). Preoperative New York Heart
Association (NYHA) functional class was available in all the patients:
4 (19%) patients were in class II, 12 (57%) patients were in class III, and
5 (24%) were in class IV. Thirteen patients required preoperative digitalis
and diuretic therapy. None of the patients had any prior cardiac surgical
procedures performed.
Anatomic diagnoses are shown in Table 1. Cardiac catheterization data
were available in 17 (81%) patients. The mean preoperative PVR was
18.3  11.6 U $ m2 (range, 7.8–45 U $ m2), which after phentolamine ad-
ministration decreased to 16.6  10.5 U $ m2 (range, 7.0–42 U $ m2). Therdiovascular Surgery c Volume 140, Number 4 845
Abbreviations and Acronyms
ASO ¼ arterial switch operation
NYHA ¼ New York Heart Association
PH ¼ pulmonary hypertension
PVOD ¼ pulmonary vascular obstructive disease
PVR ¼ pulmonary vascular resistance
TGA ¼ transposition of the great arteries
VSD ¼ ventricular septal defect
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Dmean peak systolic pulmonary arterial pressure was 91  13 mm Hg (range,
68–115 mm Hg). The mean preoperative systolic pulmonary/systemic arte-
rial pressure ratio was 0.99  0.10 (range, 0.79–1.20). The mean preoper-
ative oxygen saturation and hematocrit value were 69%  9.5% (range,
48%–86%) and 60%  12% (28%–76%), respectively.
Early mortality was defined as death occurring within 30 days of opera-
tion or at any time during the operative hospitalization. All patients dis-
charged from the hospital were followed up to the end date of the study
(September 2009). The patients were asked to return to the hospital for echo-
cardiographic and clinical evaluations at 3 and 6 postoperative months and
then at least once each year.
All analyses were performed using SPSS statistical software (SPSS, Inc,
Chicago, Ill). Preoperative and postoperative continuous variables were
compared using paired-samples t tests. Comparisons of preoperative data
between those who subsequently displayed persistent severe PH and those
who showed reversible PVOD after palliative ASO were drawn using the
independent-samples t test. Changes in preoperative and postoperative
New York Heart Association classification were analyzed using the
Wilcoxon test.RESULTS
All the operations were performed through a median ster-
notomy with cardiopulmonary bypass. All the patients un-
derwent ASO as described by current congenital heart
surgery textbooks. Two early cases were performed without
closing the VSDs, whereas in all the others the VSDs were
closed using either autologous pericardium, treated with
0.6% glutaraldehyde for 15 minutes (n ¼ 11), or polytetra-
fluoroethylene (n ¼ 8) fenestrated patches. The diameters of
fenestrations varied from 4 to 10 mm. The sizes of fenestra-
tions were determined according to one half the expected
aortic annulus size for each child. Associated cardiac proce-
dures included patent ductus arteriosus ligation in 8, atrial
septal defect repair in 5, and aortopulmonary window repair
in 1 patient. The median aortic occlusion time was 148 min-
utes (range, 84–193 minutes). Deep hypothermic circulatory
arrest was used in 4 patients. The median postoperative me-
chanical ventilation time was 22 hours (range, 4–410 hours).
Early mortality was 14.3% (3 patients). Causes of early
death were cardiac failure, sudden cardiac arrest induced
by pulmonary hypertensive crisis, and persistent pulmonary
hemorrhage in 1 patient each. The patient who died of
cardiac failure was seen early on in our experience. He
was 5 years old at the time of operation with a single coro-
nary ostium at the right coronary sinus giving rise to the right846 The Journal of Thoracic and Cardiovascular Surgcoronary, the left anterior descending, and the left circum-
flex arteries. The VSD was left open. He could not be
weaned from cardiopulmonary bypass. We believed that
the cause of death was myocardial ischemia owing to less
than ideal transfer of the single coronary button. Another
5-year-old child died of sudden cardiac arrest 5 days after
palliative ASO and extubated for 3 days. His VSD was
closed with a pericardial patch with a 6-mm fenestration. Se-
vere PH and right-to-left shunt were found on postoperative
echocardiography. We believed that his cardiac arrest was
induced by pulmonary hypertensive crisis. The patient
who died of persistent pulmonary hemorrhage was also
found to have severe PH on postoperative echocardiogra-
phy. We again believed that the pulmonary hemorrhage
was related to PH. Nitric oxide and sildenafil were both
used in the last 2 patients postoperatively. Oral sildenafil, in-
haled nitric oxide, and continuous intravenous prostacyclin
were selectively used postoperatively in most of the patients
in this cohort according to the conditions of each patient.
The median postoperative length of stay for the early sur-
vivors was 17 days (range, 7–33 days). Eight patients had
major morbidities including pleural effusion requiring thor-
acentesis (n ¼ 2), pneumonia requiring prolonged (>72
hours) antimicrobial therapy (n ¼ 3), acute renal failure
requiring peritoneal dialysis before discharge (n ¼ 1), and
mediastinal re-exploration for bleeding (n ¼ 2). At late
follow-up, the mean systemic arterial oxygen saturation
increased from 69% preoperatively to 93% postoperatively
(P< .001), and the mean hematocrit value decreased from
60% preoperatively to 43% (P< .001; Table 2).
The mean follow-up for the 18 early survivors was 4.0
years with a maximum of 9.5 years. There was 1 late death
that occurred 3 months after surgery (Figure 1). The esti-
mated postoperative pulmonary pressure, obtained by echo-
cardiography just before discharge in the patient who died
late, was 45 mm Hg. The cause of late death was sudden car-
diac arrest in an outlying hospital. The details surrounding
this death were not clear. Three patients with preoperative
PVR of 20, 15, and 12 U $ m2, respectively, underwent per-
cutaneous closure using Amplatzer occluder devices of their
VSD patch fenestrations when persistent left-to-right shunts
at the ventricular level and normal-to-mild (<50 mm Hg) es-
timated systolic pulmonary arterial pressures were docu-
mented on Doppler echocardiograms 7, 9, and 31 months
after their palliative ASO, respectively. Four other patients
who were documented to have left-to-right shunts at the ven-
tricular level and mild-to-moderate (50–70 mm Hg) esti-
mated systolic pulmonary arterial pressures by Doppler
echocardiograms were advised to continue watchful
follow-up periodically. In 1 patient who underwent concom-
itant aortopulmonary window (type I) repair and palliative
ASO, Doppler echocardiography 10 months later found
a spontaneously closed fenestration and normal pulmonary
arterial pressure. She is alive and well at the time of thisery c October 2010
TABLE 1. Anatomic diagnoses
Diagnosis n
TGA, VSD 8
TGA, VSD, PDA 7
TGA, VSD, ASD 4
TGA, VSD, PDA, ASD 1
TGA, VSD, APW 1
TGA, Transposition of the great arteries; VSD, ventricular septal defect; PDA, patent
ductus arteriosus; ASD, atrial septal defect; APW, aortopulmonary window.
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Dwriting. All together, 8 patients (44% of the early survivors)
in our review showed a regression of pulmonary arterial
pressure. Nevertheless, the other 9 patients (50% of the early
survivors) displayed right-to-left or bidirectional shunt and
persistent severe PH (Table 3). There were no significant dif-
ferences in age, preoperative PVR (including PVR after
phentolamine infusion), systolic pulmonary/systemic arte-
rial pressure ratio, oxygen saturation, and hematocrit be-
tween these 9 patients and those who demonstrated
postoperative regression of their PH (P> .05, Table 4).
The indications for percutaneous closure of fenestrations
are (1) stable hemodynamics and good cardiopulmonary
function and (2) persistent left-to-right shunt and estimated
systolic pulmonary arterial pressure less than 50 mm Hg
documented by 2 consecutive Doppler echocardiograms
over a period of 6 months.TABLE 2. Preoperative and postoperative oxygen saturation, hematocrit,
Preoperative
Patient no. SaO2 (%) Hct (%) PVR (U $ m
1 66 45 45
2 78 73 7.8
3 81 70 20
4 72 74 26
5 55 60 42
6 76 59 10
7 65 62 8
8 76 28
9 76 59 11
10 62 48
11 71 50 9
12 64 72 18
13 48 71 29
14 55 64 11
15 67 64 11
16 76 59
17 65 43 10
18 67 72 12.7
19 67 76
20 86 51 25
21 80 52 15
Mean 69  9.5 60  12 18.3  11.6
SaO2, Arterial oxygen saturation; Hct, hematocrit; PVR, pulmonary vascular resistance; PVR
0
patients. Oxygen saturation data were obtained on room air; ypostoperative hematocrit was
istration, P¼ .006; xpreoperative systemic oxygen saturation versus postoperative arterial sa
The Journal of Thoracic and CaDuring the follow-up period, 1 patient had moderate aor-
tic valve regurgitation, 2 had mild coarctation of the aorta, 1
had mild mitral valve regurgitation, and 2 had mild-to-
moderate tricuspid insufficiency; none of these required sur-
gical intervention.
NYHA functional class was available in 17 of the 18 early
survivors. Functional class was significantly improved post-
operatively: 13 patients were in class I and 4 in class II
(P< .001, Figure 2). Electrocardiographic data were avail-
able in 17 patients, all showing sinus rhythms.COMMENT
ASO has been proved to be the preferred choice for most
neonates with TGA.1-3 Pulmonary vascular disease in
children with TGA progresses rapidly during early
infancy. In TGA associated with VSD with or without
patent ductus arteriosus, the development of PVOD is
faster owing to high pulmonary blood flow, high
pulmonary artery pressure, hypoxemia, and polycythemia.
Delayed diagnosis could result in progressive PVOD.
Palliative atrial switch operation has been attempted to
treat patients with TGA, VSD, and severe PVOD in the
past with apparently good long-term results.5,6 However,
a not insignificant portion of this patient population
experienced symptomatic or even deadly arrhythmia and
reoperation for baffle obstruction.6,7 Pridjian,8 Elizari,9 andand PVR variables*
Postoperative
2) PVR0 (U $ m2) SaO2 (%) Hct (%)y
38 95 35
7 92 45
15 96 42
24
42
9 93 45
8 92 38
91 45
11 90 52
93 36
8.2 96 38
18 88 55
25 86 48
10.6
11 95 50
91 43
10.5 98 45
12 94 40
93 40
23 98 46
10 99 38
16.6  10.5z 93  3.4x 43  5.6k
, preoperative PVR after phentolamine administration. *Data were unavailable on some
obtained at late follow-up; zpreoperative PVR versus PVR after phentolamine admin-
turation, P<.001; kpreoperative hematocrit versus postoperative hematocrit, P<.001.
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FIGURE 1. Actuarial survival curve with the hospital mortality included.
TABLE 4. Comparisons of preoperative data of the early survivors
between those who displayed persistent severe PH and those who
showed reversible PVOD after palliative ASO
Data Persistent severe PH Reversible PVOD P value
Age (y) 4.4  4.6 2.7  2.1 .108
SaO2 (%) 68.6  9.1 74.1  8.5 .784
Hct (%) 61.7  9.7 52.9  14.3 .393
Pp/Ps 1.03  0.13 0.95  0.06 .081
PVR 17.4  13.3 15.5  6.0 .147
PVR0 15.8  10.9 13.2  5.3 .122
PH, Pulmonary hypertension; PVOD, pulmonary vascular obstructive disease; ASO,
arterial switch operation; SaO2, oxygen saturation; Hct, hematocrit; Pp/Ps, systolic pul-
monary/systemic arterial pressure ratio; PVR, pulmonary vascular resistance; PVR0,
PVR after phentolamine administration.
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Dtheir colleagues reported the application of palliative ASO in
2 patients without closing the VSDs and both patients
enjoyed near normal lives postoperatively, although their
PVOD did not improve. By contrast, Nakajima and associ-
ates10 reported a series of 19 patients (ages ranging from
7 months to 14 years) with TGA with or without VSD and
all with severe PH who underwent the atrial switch operation
or ASO, with some patients showing improvement of their
PVOD postoperatively. In our series, except the 2 patients
early on in our experience whose VSDs were left open, all
the other patients undergoing palliative ASO had their
VSDs closed with fenestrated patches. This approach offers
the distinct advantage of subsequent nonsurgical closure of
the residual shunt when echocardiography during follow-
up demonstrates persistent left-to-right shunt and acceptable
estimated systolic pulmonary arterial pressure compared
with simply leaving the VSD open during the palliative
ASO. In our study, 8 of the 18 early survivors showed a sig-
nificant decrease of pulmonary arterial pressure, with 4 of
them eventually achieving complete VSD closures. The in-
dication for palliative ASO can also be extended to patients
with TGA and intact ventricular septum and severe PVOD in
whom a VSD is created at the time of palliative ASO11 and
patients with other transposition hemodynamics, VSD (eg,
Taussig–Bing anomaly), and severe PVOD.12,13
Our decision to size the fenestration was based on one half
of the expected aortic annulus diameter of the child. We
believe that half the aortic annulus size is large enough to
decompress the right ventricle. Novick and coworkers14TABLE 3. Late results of early survivors
Results No. of patients
Reversible PVOD 8/18 (44%)
Fenestration closed 4/8 (50%)
Fenestration not closed 4/8 (50%)
Irreversible PVOD 9/18 (50%)
Late death 1/18 (6%)
PVOD, Pulmonary vascular obstructive disease.
848 The Journal of Thoracic and Cardiovascular Surgreported a large group of fenestrated flap valve double patch
closure of VSD in children with elevated PVR in 2005. They
sized the fenestration in a similar fashion as we did and
achieved a good result. Some researchers believe that the
size of the fenestration must be nearly the size of the aortic
annulus (nonrestrictive) to provide effective right ventricular
decompression. However, any postoperative regression of
pulmonary arterial pressure will be masked by massive
left-to-right shunt affected or even sustained by the nonre-
strictive fenestration.
Haworth, Radley, and Yacoub15 analyzed lung biopsy tis-
sue of patients with TGA/VSD and found that increased
PVR was associated with cellular intimal proliferation with-
out developing the classic grade III and IV pulmonary vas-
cular disease characterized by intimal fibrosis and dilation.
PVR will increase when most of the pulmonary arteries
are narrowed and also when the pulmonary arteries are fewer
than normal. There are more intra-acinar pulmonary arteries
than normal in certain congenital heart lesions such as aortic
atresia and stenosis and fewer in pulmonary atresia.16,17
Therefore, certain lesions such as TGA/VSD and truncus
arteriosus, which develop an early increase in PVR, mightFIGURE 2. Preoperative (Preop) and postoperative (Postop) New York
Heart Association (NYHA) functional class.
ery c October 2010
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Dhave fewer intra-acinar pulmonary arteries at term. In nor-
mal children, there is a continued increase in the number
of intra-acinar arteries after birth until lung growth is com-
pleted by 8 to10 years of age.18,19 The capability of
regeneration of intra-acinar arteries in children with TGA/
VSD is not known. However, these findings suggest that
the potential capacity of regeneration of pulmonary vessels
may lead to the potential reversibility of PVOD after sur-
gery.4 On the other hand, some patients with TGA have se-
vere irreversible PVOD develop in early infancy,20 even
after successful surgery.21,22 The pathologic differences
between these 2 groups of patients with reversible and
irreversible PVOD may contribute to the distinct outcomes
of these patients.23
ASO for TGA has shown very low (2%–5%) early mor-
tality.24,25 However, reports of palliative ASO for TGA/
VSD with PVOD are few and the clinical data currently
available are still insufficient for any meaningful
interpretation. Burkhart and coworkers7 reported a series
of patients who underwent palliative atrial switch for
TGA/VSD with PVOD with an early mortality of 21%
and a 15-year survival of 54%. Our study showed an early
mortality of 14.3% and a late mortality of 5.6% during
a mean follow-up period of 4 years. These figures appeared
acceptable considering the poor prognosis of children with
TGA/VSD and PVOD if untreated.
Although our postoperative treatment protocol including
nitric oxide, prostacyclin, and sildenafil has been used to
manage PH and improve hemodynamics, 2 of the 3 early
deaths were still related to severe PH, indicating that severe
postoperative PH was still a major threat to survival. Extra-
corporeal membrane oxygenator support might be an option
to salvage postoperative patients with unstable hemodynam-
ics and cardiopulmonary dysfunction.
In contrast to the atrial switch procedure, palliative ASO
seems to have fewer long-term complications such as symp-
tomatic or even deadly arrhythmias and baffle obstruction,
which might require reoperative intervention, and therefore
should be considered as another option in the congenital
heart surgeons’ armamentarium. Longer-term follow-up
(10 years and more) as well as a prospective randomized trial
comparing the palliative atrial switch operation and pallia-
tive ASO may ultimately define the true validity of both pro-
cedures in dealing with these groups of unfortunate children
with late presentation of TGA/VSD and severe PVOD in
many developing countries of the world.
In conclusion, palliative ASO can be performed in patients
with TGA/VSD and severe PVOD. Postoperative PVR
might be reversible in some patients. Closing the VSD
with a fenestrated patch is suggested for further possible per-
cutaneous occlusion of fenestration. Systemic arterial satura-
tion and quality of life can be significantly improved. Low
incidence of long-term complications and reoperation might
be the advantage over the palliative atrial switch procedure.The Journal of Thoracic and CaReferences
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